Showing results (41-50 of 1,365) with videos related to

Sort By:
Pageof 137
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Consensus guidelines for lumbar puncture in patients with neurological diseasesSebastiaan Engelborghs, Ellis Niemantsverdriet, Hanne Struyfs, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|June 13, 2017
Longitudinal changes in amyloid positron emission tomography and volumetric magnetic resonance imaging in the nondemented Down syndrome populationPatrick J Lao, Ben L Handen, Tobey J Betthauser, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|September 15, 2016
Cognitive impairment among World Trade Center responders: Long-term implications of re-experiencing the 9/11 terrorist attacksSean A P Clouston, Roman Kotov, Robert H Pietrzak, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 14, 2022
Crosswalk study on blood collection-tube types for Alzheimer's disease biomarkersErin M Jonaitis, Henrik Zetterberg, Rebecca Langhough Koscik, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|February 14, 2022
Validation of the National Alzheimer's Coordinating Center (NACC) Lewy Body Disease Module neuropsychological testsAnnalise Rahman-Filipiak, Shima Sadaghiyani, Katrail Davis, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|October 25, 2021
Objective subtle cognitive decline and plasma phosphorylated tau181: Early markers of Alzheimer's disease-related declinesKelsey R Thomas, Katherine J Bangen, Emily C Edmonds, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|April 27, 2022
Genome- and epigenome-wide studies of plasma protein biomarkers for Alzheimer's disease implicate TBCA and TREM2 in disease riskRobert F Hillary, Danni A Gadd, Daniel L McCartney, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 1, 2022
Vascular risk profile and white matter hyperintensity volume among Mexican Americans and non-Hispanic Whites: The HABLE studyKevin S King, Raul M Vintimilla, Meredith N Braskie, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|March 1, 2022
Population attributable fraction of modifiable risk factors for dementia in ChileRodrigo C Vergara, Pedro Zitko, Andrea Slachevsky, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|November 29, 2023
Validation of 3- and 5-point severity scales to assess ARIA-ELuc Bracoud, Gregory Klein, Marco Lyons, et al.
Pageof 137